The Efficacy and Safety of Transcatheter Arterial Embolization to Treat Renal Hemorrhage after Percutaneous Nephrolithotomy

Table 4

The comparison of laboratory examination data perioperative and long-term renal function outcomes between groups.

Variable	TAE group	Control group	P values
	(n=32)	(n=89)
Preoperative renal function
SCr (mg/dl)	0.95 ± 0.26	0.91 ± 0.23	0.446
eGFR (ml/min/1.73m^2)	86.77 ± 18.76	88.87 ± 15.99	0.552
Postoperative renal function
SCr	0.94 ± 0.25	0.93 ± 0.22	0.761
eGFR (ml/min/1.73m^2)	87.60 ± 20.24	86.41 ± 18.95	0.775
Renal function at lost follow-up
SCr (mg/dl)	0.95 ± 0.30	0.92 ± 0.28	0.635
eGFR (ml/min/1.73m^2)	86.18 ± 15.78	85.11 ± 16.95	0.770
Renal function change between preoperational and at lost follow-up
SCr (P value)	0.857	0.698
eGFR (P value)	0.715	0.125

eGFR: estimated glomerular filtration rate; SCr: serum creatinine; and TAE: transcatheter arterial embolization. P<0.05.